- 期刊
Long-Term Effect of Interferon Alfa-2B Plus Ribavirin Therapy on Incidence of Hepatocellular Carcinoma in Patients with Hepatitis C Virus-Related Cirrhosis
延伸閱讀
- 蘇容緯（2008）。The Long-term Prognosis and Medical Resource Utilization of Hepatocellular Carcinoma Patients by Surgical Factors and Patterns of Viral Hepatitis〔碩士論文，高雄醫學大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0011-1707200815183800
- Hung, F. C., Lee, C. M., Lu, S. N., Wang, J. H., Tung, H. D., & Changchien, C. S. (2004). Efficacy and Predictors of Response to Combination Therapy of Interferon and Ribavirin for Chronic Hepatitis C. 臺灣消化醫學雜誌, 21(3), 226-226. https://www.airitilibrary.com/Article/Detail?DocID=10137696-200409-21-3-226-226-a
- Wu, C. F. (2006). Long-Term Patterns of Hepatitis B Viral Load and Risk of Hepatocellular Carcinoma: A Case-Cohort Study [master's thesis, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU.2006.00656
- Wen, S. C., Cheng, L. C., Hsu, J. H., Shih, P. C., Tsai, C. C., & Kuo, W. H. (2016). Assessment of Factors Correlated with Ribavirin Dose Reduction Due to Hemolytic Anemia during Treatment in Patients with Chronic Hepatitis C Treated with Pegylated Interferon and Ribavirin Combination Therapy. 寶建醫護與管理雜誌, 13(1&2), 1-8. https://www.airitilibrary.com/Article/Detail?DocID=16830806-201606-201701130020-201701130020-1-8
- Hwang, S. J., Wang, Y. J., Lee, S. D., Chu, C. J., & Chang, F. Y. (2005). Combination Interferon α-2b Plus Ribavirin Therapy in Patients with Chronic Hepatitis C with Resistance to or Relapse after Interferon Monotherapy. 北市醫學雜誌, 2(3), 254-264. https://doi.org/10.6200/TCMJ.2005.2.3.04